LexaGene Holdings Inc.
LXG.V
LXG.VLexaGene Holdings Inc.
Toronto Stock Exchange Ventures0.11
CAD
- -
- -
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Dr. John F. Regan
- Full Time Employees
- 33
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 500 Cummings Center Beverly MA United States of America 01915
- IPO Date
- Jul 10, 2018
- Website
- lexagene.com
- Similar Companies
- Business
- LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.